Inhibition of accelerated graft arteriosclerosis by gene transfer of soluble fibroblast growth factor receptor-1 in rat aortic transplants

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 6, 2004, Pages 1081-1086

  Luo, Wensheng ^a   Liu, Ailian ^a   Chen, Yong ^a   Lim, Hyung M ^a   Marshall Neff, Jennifer ^c   Black, James H ^a   Baldwin III, William ^a   Hruban, Ralph H ^a   Stevenson, Susan C ^c   Mouton, Peter ^a   Dardik, Alan ^a   Ballermann, Barbara J ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic rejection; Neointima; Transplant vasculopathy; Transplantation

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ADENOVIRUS; ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; GENE TRANSFER; GRAFT REJECTION; HEART GRAFT; HUMAN; HUMAN CELL; KIDNEY GRAFT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; VASCULAR DISEASE;

ADENOVIRIDAE; ANIMALS; AORTA; AORTIC DISEASES; ARTERIOSCLEROSIS; CELLS, CULTURED; DNA, COMPLEMENTARY; GENE THERAPY; GENETIC VECTORS; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED F344; RATS, INBRED STRAINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; SOLUBILITY; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 2942511346     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000128201.65443.ea     Document Type: Article

References (35)

1. Weis M, von Scheidt W. Coronary artery disease in the transplanted heart. Annu Rev Med. 2000;51:81-100.
2. Paul LC. Pathophysiology of chronic renal allograft rejection. Transplant Proc. 1999;31:2715-2716.
3. Reidy MA, Lindner V. Basic FGF and growth of arterial cells. Ann N Y Acad Sci. 1991;638:290-299.
4. Gajdusek CM, Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol. 1989; 139:570-579.
5. Carreira CM, LaVallee TM, Tarantini F, Jackson A, Lathrop JT, Hampton B, Burgess WH, Maciag T. S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro. J Biol Chem. 1998;273:22224-22231.
6. Moscatelli D. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem. 1992;267:25803-25809.
7. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ Res. 1993;73:589-595.
8. Clasper S, Vekemans S, Fiore M, Plebanski M, Wordsworth P, David G, Jackson DG. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem. 1999;274:24113-24123.
9. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
10. Nguyen HC, Steinberg BM, LeBoutillier M III, Baumann FG, Rifkin DB, Grossi EA, Galloway AC. Suppression of neointimal lesions after vascular injury: a role for polyclonal anti-basic fibroblast growth factor antibody. Surgery. 1994;116:456-461; discussion 461-462.
11. Nabel EG, Yang ZY, Plautz G, Forough R, Zhan X, Haudenschild CC, Maciag T, Nabel GJ. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature. 1993;362:844-846.
12. Zhao XM, Yeoh TK, Frist WH, Porterfield DL, Miller GG. Induction of acidic fibroblast growth factor and full-length platelet-derived growth factor expression in human cardiac allografts. Analysis by PCR, in situ hybridization, and immunohistochemistry. Circulation. 1994;90:677-685.
13. Zhao XM, Frist WH, Yeoh TK, Miller GG. Modification of alternative messenger RNA splicing of fibroblast growth factor receptors in human cardiac allografts during rejection. J Clin Invest. 1994;94: 992-1003.
14. Miller GG, Davis SF, Atkinson JB, Chomsky DB, Pedroso P, Reddy VS, Drinkwater DC, Zhao XM, Pierson RN. Longitudinal analysis of fibroblast growth factor expression after transplantation and association with severity of cardiac allograft vasculopathy. Circulation. 1999;100:2396-2399.
15. Shaddy RE, Hammond EH, Yowell RL. Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients. Am J Cardiol. 1996;77:1210-1215.
16. Kerby JD, Verran DJ, Luo KL, Ding Q, Tagouri Y, Herrera GA, Diethelm AG, Thompson JA. Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection. Transplantation. 1996;62:467-475.
17. Paul LC, Saito K, Davidoff A, Benediktsson H. Growth factor transcripts in rat renal transplants. Am J Kidney Dis. 1996;28:441-450.
18. Kerby JD, Verran DJ, Luo KL, Ding Q, Tagouri Y, Herrera GA, Diethelm AG, Thompson JA. Immunolocalization of FGF-1 and receptors in glomerular lesions associated with chronic human renal allograft rejection. Transplantation. 1996;62:190-200.
19. Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell. 2000;101:413-424.
20. Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993;60:1-41.
21. Landgren E, Klint P, Yokote K, Claesson-Welsh L. Fibroblast growth factor receptor-1 mediates chemotaxis independently of direct SH2-domain protein binding. Oncogene. 1998;17:283-291.
22. LaVallee TM, Prudovsky IA, McMahon GA, Hu X, Maciag T. Activation of the MAP kinase pathway by FGF-1 correlates with cell proliferation induction while activation of the Src pathway correlates with migration. J Cell Biol. 1998;141:1647-1658.
23. Olson NE, Kozlowski J, Reidy MA. Proliferation of intimal smooth muscle cells. Attenuation of basic fibroblast growth factor 2-stimulated proliferation is associated with increased expression of cell cycle inhibitors. J Biol Chem. 2000;275:11270-11277.
24. Hanneken A, Ying W, Ling N, Baird A. Identification of soluble forms of the fibroblast growth factor receptor in blood. Proc Natl Acad Sci U S A. 1994;91:9170-9174.
25. Hanneken A, Maher PA, Baird A. High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells: implications for the modulation of FGF-2. J Cell Biol. 1995;128: 1221-1228.
26. Ueno H, Gunn M, Dell K, Tseng A Jr, Williams L. A truncated form of fibroblast growth factor receptor 1 inhibits signal transduction by multiple types of fibroblast growth factor receptor. J Biol Chem. 1992;267:1470-1476.
27. Chellaiah A, Yuan W, Chellaiah M, Ornitz DM. Mapping ligand binding domains in chimeric fibroblast growth factor receptor molecules. Multiple regions determine ligand binding specificity. J Biol Chem. 1999;274:34785-34794.
28. Amaya E, Musci TJ, Kirschner MW. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell. 1991;66:257-270.
29. McFarlane S, Zuber ME, Holt CE. A role for the fibroblast growth factor receptor in cell fate decisions in the developing vertebrate retina. Development. 1998;125:3967-3975.
30. Yukawa H, Miyatake SI, Saiki M, Takahashi JC, Mima T, Ueno H, Nagata I, Kikuchi H, Hashimoto N. In vitro growth suppression of vascular smooth muscle cells using adenovirus-mediated gene transfer of a truncated form of fibroblast growth factor receptor. Atherosclerosis. 1998;141:125-132.
31. Legare JF, Issekutz T, Lee TD, Hirsch G. CD8+ T lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol. 2000;157:859-865.
32. Hruban RH, Kasper EK, Gaudin PB, Baughman KL, Baumgartner WA, Reitz BA, Hutchins GM. Severe lymphocytic endothelialitis associated with coronary artery spasm in a heart transplant recipient. J Heart Lung Transplant. 1992;11:42-47.
33. Moons L, Shi C, Ploplis V, Plow E, Haber E, Collen D, Carmeliet P. Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest. 1998;102:1788-1797.
34. Sata M, Luo Z, Walsh K. Fas ligand overexpression on allograft endothelium inhibits inflammatory cell infiltration and transplant-associated intimal hyperplasia. J Immunol. 2001;166:6964-6971.
35. Saiki M, Mima T, Takahashi JC, Tani S, Yukawa H, Ueno H, Mikawa T, Itoh N, Kikuchi H, Hashimoto N, Miyatake S. Adenovirus-mediated gene transfer of a truncated form of fibroblast growth factor receptor inhibits growth of glioma cells both in vitro and in vivo. J Neurooncol. 1999;44:195-203.